Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case report describes an 18-month-old boy who developed a rare phototoxic skin reaction to terbinafine, likely triggered by sunlight exposure, which resolved after treatment with corticosteroid cream and sun avoidance.

Oral cyclosporin doesn't stop hair loss.

A fungal infection can look like a different scalp condition in teens, leading to wrong treatment until proper tests are done.

This case report found that dermoscopy, showing characteristic "comma" and "corkscrew" hairs, effectively identified tinea capitis in a 7-year-old girl, allowing for early treatment before confirmation with fungal culture.

This case report identifies a 13-year-old boy with disseminated tinea incognito, emphasizing the importance of considering fungal infections when red and scaly lesions persist despite corticosteroid treatment.

This report describes a case where a patient's rash initially treated as atopic dermatitis with topical steroids was later diagnosed as tinea incognito, an atypical dermatophyte infection that worsened due to steroid use, but was effectively treated with oral and topical antifungals.

This case report highlights the importance of maintaining clinical suspicion for tinea incognito in patients with central centrifugal cicatricial alopecia who do not respond to typical corticosteroid treatments, as misdiagnosis can complicate treatment.

This article reviews the diagnosis and treatment of tinea capitis in children, noting that newer antifungal agents can offer effective systemic therapy alongside supportive topical treatments; it reports no new clinical findings.

This study reported an increase in tinea capitis in Stockholm children, mainly caused by Trichophyton violaceum and associated with immigration from Africa and family spread.

This review discusses the challenges in diagnosing tinea capitis and highlights the need for laboratory confirmation and systemic treatment due to the limited effectiveness of topical antifungals; no new clinical results are presented.

This report details a rare case of favus in Japan, identifying Trichophyton schoenleinii in a 63-year-old woman through DNA sequencing, who was successfully treated with oral terbinafine and topical luliconazole.

This case report describes a 26-year-old woman who developed an unusual fungal skin infection, possibly facilitated by using a microneedling device at home, highlighting the need for safer procedures and aftercare protocols to prevent infection.

This case report describes a high school wrestler whose forearm rash was initially misdiagnosed as eczema, later identified as Majocchi's granuloma, and successfully treated with oral antifungal therapy after a biopsy.

In this study, outbreaks of tinea capitis caused by Trichophyton tonsurans were linked to hairdressing in Sardinian barbershops, with 10 young adult men developing the infection following haircuts; timely treatment is crucial to prevent complications like scarring alopecia.

This case report describes a 52-year-old woman with erythema annulare centrifugum after using topical luliconazole and oral itraconazole, suggesting a drug-induced reaction confirmed by a positive rechallenge test.

This review presents European guidelines for treating tinea capitis, noting systemic antifungals are essential, with griseofulvin preferred for Microsporum infections and newer antifungals viable for Trichophyton but often costlier.

In this article review, it was reported that systemic oral antifungal treatments are essential for effectively managing tinea capitis, as topical antifungals alone cannot reach the hair follicle roots but may reduce spore transmission when used alongside oral medications.

Treat scalp and beard fungal infections early with oral antifungal medication and sometimes topical therapy, avoiding unnecessary allergy tests and surgery.

This paper discusses tinea capitis in adults, emphasizing that it particularly affects postmenopausal African American or Black women, and notes challenges in treatment due to antifungal resistance.

This review discusses skin appendages like hair and nails as indicators of local and systemic pathologies, emphasizing conditions such as inflammatory diseases and infections, but reports no new clinical findings.

In this case report, a 34-year-old woman with black dot tinea capitis did not respond to oral Itraconazole but was successfully treated with Terbinafine.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

This review discusses various skin-related conditions affecting hair and nails, highlighting associations with systemic pathologies but reports no new clinical findings.

In this study, terbinafine reached high concentrations in stratum corneum and sebum after oral administration, with drug levels remaining above fungicidal concentrations for over three weeks.

Treatment with oral terbinafine and topical enilconazole was successful in resolving a Trichophyton dermatophytosis outbreak in L'Hoest's monkeys, with complete mycological cure achieved after eight weeks.

This review discusses the developments in antifungal treatments for dermatophyte infections since 2008, reporting no new oral agents but introducing newer topical options like efinaconazole and tavaborole.

In this case report, an 80-year-old male with severe sycosis barbae and no animal contact was successfully treated with oral terbinafine after diagnostic sequencing identified Trichophyton verrucosum as the infecting species.

In this case report, half-siblings with bullous congenital ichthyosiform erythroderma were found to have a susceptibility to Trichophyton rubrum infection, successfully treated with oral terbinafine.

In this case study, a 20-year-old man with dermatitis initially misdiagnosed as caused by Herpes simplex was found to have a fungal infection, Trichophyton mentagrophytes, and successfully treated with oral terbinafine and ketoconazole products.

In this veterinary case study, a 5-year-old Labrador with pruritus and alopecia tested positive for Malassezia pachydermatitis and recovered after treatment with oral terbinafine and topical ketoconazole.